4188 — Mitsubishi Chemical Balance Sheet
0.000.00%
- ¥977bn
- ¥3tn
- ¥4tn
- 51
- 92
- 20
- 58
Annual balance sheet for Mitsubishi Chemical, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | C2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 345,839 | 397,395 | 296,874 | 371,693 | 377,728 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 698,516 | 716,392 | 825,996 | 808,787 | 852,353 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,749,281 | 1,797,534 | 1,986,116 | 2,149,618 | 2,191,636 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,742,216 | 1,813,838 | 1,899,695 | 1,907,898 | 2,043,330 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 5,132,149 | 5,287,228 | 5,573,871 | 5,774,348 | 6,104,513 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,636,499 | 1,492,506 | 1,419,293 | 1,663,830 | 1,724,912 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 3,961,927 | 4,050,889 | 4,115,794 | 4,209,650 | 4,341,066 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,170,222 | 1,236,339 | 1,458,077 | 1,564,698 | 1,763,447 |
Total Liabilities & Shareholders' Equity | 5,132,149 | 5,287,228 | 5,573,871 | 5,774,348 | 6,104,513 |
Total Common Shares Outstanding |